ABVC BioPharma, Inc. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ABVC BioPharma, Inc. (ABVC) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$525.09 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-08-12
- ABVC BioPharma, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for the quarter ending 2026-03-31 was -$354.89K.
- ABVC BioPharma, Inc. effective income tax rate reconciliation at federal statutory income tax rate, amount for the quarter ending 2025-03-31 was -$198.07K.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 3 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 6 month |
|---|---|---|
| 2026-06-30 | -$525.09K 10-Q · filed 2026-08-12 | |
| 2026-03-31 | -$354.89K 10-Q · filed 2026-05-18 | |
| 2025-06-30 | -$683.21K 10-Q · filed 2026-08-12 | |
| 2025-03-31 | -$198.07K 10-Q · filed 2026-05-18 |